Position in BIOA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,423,904
+$2,180,472 QoQ
Shares Held
138,588
+653.2% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,198,269,231 across 49 Drug Manufacturers - Specialty & Generic names. BIOA ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,787,019 | $1,059,666,526 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,418,897 | $318,665,490 | |
| 3 | ALKS |
Alkermes plc.
|
6,160,428 | $217,832,734 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,859,728 | $108,857,232 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,705,222 | $88,142,925 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,989,100 | $55,358,132 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,469,449 | $48,594,678 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
2,118,080 | $43,971,340 |
All Filings in BIOA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,423,904 | 138,588 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $243,432 | 18,400 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $840,840 | 143,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $368,792 | 89,296 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||